| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 08/14/2003 | WO2003067215A2 Automatic threshold setting and baseline determination for real-time pcr |
| 08/14/2003 | WO2003067213A2 Modulation of sulfate permease for photosynthetic hydrogen production |
| 08/14/2003 | WO2003067211A2 An improvement in a method bacterial endospore quantification using lanthanide dipicolinate luminescence |
| 08/14/2003 | WO2003067210A2 Methods and compositions for detecting the activation state of the multiple proteins in single cells |
| 08/14/2003 | WO2003066930A1 Diamond electrode |
| 08/14/2003 | WO2003066908A1 Detection method using dissociated rolling circle amplification |
| 08/14/2003 | WO2003066907A1 Seal for microtiter plate and methods of use thereof |
| 08/14/2003 | WO2003066905A1 Colorimetric genetic test for clinically significant tnf polymorphism and methods of use thereof |
| 08/14/2003 | WO2003066904A2 Methods for determining the response of cells to vegf and uses thereof |
| 08/14/2003 | WO2003066903A2 Genetic markers for bone mass |
| 08/14/2003 | WO2003066901A2 Nucleic acid analysis using type is restriction endonucleases |
| 08/14/2003 | WO2003066900A2 Eif4e gene mutations and potyvirus resistance |
| 08/14/2003 | WO2003066899A1 Digital identification of genetic materials and methods for acquiring data for it |
| 08/14/2003 | WO2003066898A1 A method for the diagnosis of lymphoproliferative diseases |
| 08/14/2003 | WO2003066897A2 Specific multiplex analysis of nucleic acids |
| 08/14/2003 | WO2003066896A2 Method for the detection of mutations |
| 08/14/2003 | WO2003066895A2 Quantitative methylation detection in dna samples |
| 08/14/2003 | WO2003066894A2 Gene probes for the detection of the oenococcus species |
| 08/14/2003 | WO2003066893A1 Methods for specific rapid detection of pathogenic food-relevant bacteria |
| 08/14/2003 | WO2003066892A1 Polymorphisms in the human gene for tpmt and their use in diagnostic and therapeutic applications |
| 08/14/2003 | WO2003066891A2 Genetic markers for the diagnosis of the expression of inverted nipples in pets, breeding animals and domestic cattle |
| 08/14/2003 | WO2003066890A2 Method for determining the methylation pattern of dna |
| 08/14/2003 | WO2003066889A2 Assay for acytyltransferase or deacetylase activity |
| 08/14/2003 | WO2003066888A2 Method and apparatus for microorganism identification |
| 08/14/2003 | WO2003066886A1 Biosensor carrying redox enzymes |
| 08/14/2003 | WO2003066885A2 Method for screening for compounds having hdac inhibitory activity |
| 08/14/2003 | WO2003066884A2 Method for labeling articles |
| 08/14/2003 | WO2003066883A2 A transcription amplification system for molecular imaging |
| 08/14/2003 | WO2003066882A2 Method and apparatus for validating dna sequences without sequencing |
| 08/14/2003 | WO2003066881A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 08/14/2003 | WO2003066880A2 Method for accessing microbial diversity |
| 08/14/2003 | WO2003066878A2 Nucleic acid analysis using layered expression scanning |
| 08/14/2003 | WO2003066877A2 Compositions and methods relating to hepatic specific genes and proteins |
| 08/14/2003 | WO2003066876A2 An apparatus and methods for using biological material to discriminate an agent |
| 08/14/2003 | WO2003066874A1 Degradation of hydrophobic ester pesticides and toxins |
| 08/14/2003 | WO2003066873A1 Esterases with lipase activity |
| 08/14/2003 | WO2003066871A2 Compositions and methods for altering biosynthesis of taxanes and taxane-related compounds |
| 08/14/2003 | WO2003066870A2 Method for detecting polymorphisms in nucleic acids |
| 08/14/2003 | WO2003066845A2 Bacteriophage lysin |
| 08/14/2003 | WO2003066842A2 Method for producing recombinant proteins in micro-organisms |
| 08/14/2003 | WO2003066841A1 Viral variants with altered susceptibility to nucleoside analogs and uses thereof |
| 08/14/2003 | WO2003066840A2 Pluripotent embryonic-like stem cells derived from teeth and uses thereof |
| 08/14/2003 | WO2003066838A1 A process for identifying a novel target for use for the development of therapeutic modalities and drugs effective against tuberculosis |
| 08/14/2003 | WO2003066831A2 Angiogenesis genes |
| 08/14/2003 | WO2003066827A2 Methods and compositions for detecting differences between nucleic acids |
| 08/14/2003 | WO2003066822A2 Truncated aggrecanase molecules |
| 08/14/2003 | WO2003066818A2 Secretion, transcription and sporulation genes in bacillus clausii |
| 08/14/2003 | WO2003066817A2 Compositions and methods for rolling circle amplification |
| 08/14/2003 | WO2003066813A2 MINRs AS MODIFIERS OF INSULIN RECEPTOR SIGNALING AND METHODS OF USE |
| 08/14/2003 | WO2003066812A2 Substituted 4,4-difluoro-4-bora-3a, 4a-diaza-s-indacene compounds for 8-color dna sequencing |
| 08/14/2003 | WO2003066809A2 Mismatch endonucleases and methods of use |
| 08/14/2003 | WO2003066808A2 Mammalian migration inducting gene and methods for detection and inhibition of migrating tumor cells |
| 08/14/2003 | WO2003066805A2 Antisense modulation of complement component c3 expression |
| 08/14/2003 | WO2003066803A2 Pyrophosphorolysis and incorporation of nucleotide method for nucleic acid detection |
| 08/14/2003 | WO2003066802A2 Gene expression analysis using nicking agents |
| 08/14/2003 | WO2003066667A2 Method and apparatus for performing submicroliter reactions with nucleic acids or proteins |
| 08/14/2003 | WO2003066611A1 Bioluminescent protease assay |
| 08/14/2003 | WO2003066579A2 Novel bicyclic hydroxamates as inhibitors of histone deacetylase |
| 08/14/2003 | WO2003066212A2 Microarray synthesis instrument and method |
| 08/14/2003 | WO2003066108A1 Inactivation of microbes in biological fluids |
| 08/14/2003 | WO2003066080A1 Compositions and methods for promoting lipid mobilization, glycogen mobilization, or both, in humans |
| 08/14/2003 | WO2003066079A2 Novel epitopes for celiac disease and autoimmune diseases, methods for detecting those and novel non-antigenic food compounds |
| 08/14/2003 | WO2003066077A2 Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (nmu1) |
| 08/14/2003 | WO2003066049A1 Combinations for the treatment of fungal infections |
| 08/14/2003 | WO2003066048A2 Use of 15-lipoxygenase inhibitors for treating and preventing bone loss |
| 08/14/2003 | WO2003066043A1 Stimulation of cpt-1 as a means to reduce weight |
| 08/14/2003 | WO2003066003A2 Anti-pathogen treatements |
| 08/14/2003 | WO2003065999A2 Proliferated cell lines and uses thereof |
| 08/14/2003 | WO2003065997A2 Anti-infarction molecules |
| 08/14/2003 | WO2003065993A2 Primary rat hepatocyte toxicity modeling |
| 08/14/2003 | WO2003065984A2 Methods and compositions for treating cardiovascular disease |
| 08/14/2003 | WO2003065979A2 Methods of diagnosis, monitoring and treatment of fertility |
| 08/14/2003 | WO2003065972A2 Methods for screening osteogenic compounds |
| 08/14/2003 | WO2003065875A2 Method and test strips for the measurement of fat loss during weight loss programs |
| 08/14/2003 | WO2003065871A2 Methods and compositions for treating hematological disorders |
| 08/14/2003 | WO2003065870A2 Digital amplification for detection of mismatch repair deficient tumor cells |
| 08/14/2003 | WO2003065795A2 An invertebrate animal model with neurodegenerative phenotype for screening and testing substances |
| 08/14/2003 | WO2003048309A3 Thermus thermophilus nucleic acid polymerases |
| 08/14/2003 | WO2003044216A3 Multiplex oligonucleotide addition and target amplification |
| 08/14/2003 | WO2003039327A3 Methods and compositions for the diagnosis of cancer susceptibilities and defective dna repair mechanisms and treatment thereof |
| 08/14/2003 | WO2003034034A3 Automated system and method for processing multiple liquid-based specimens |
| 08/14/2003 | WO2003033721A3 Proteomic interaction and genomic action determinations in the presence of associated redox state conditions |
| 08/14/2003 | WO2003031934A3 Identification of oligonucleotides for the capture, detection and quantitation of hepatitis b viral dna |
| 08/14/2003 | WO2003031568A8 Intracellular signaling molecules |
| 08/14/2003 | WO2003029924A3 Adaptive baseline algorithm for quantitative pcr |
| 08/14/2003 | WO2003025201A3 Methods of using 5433, a human calcium channel family member |
| 08/14/2003 | WO2003024314A3 Methods and compositions for detection of single nucleotide polymorphisms |
| 08/14/2003 | WO2003023365A3 Electrochemical sensor using intercalative, redox-active moieties |
| 08/14/2003 | WO2003022995A3 Nucleic acid and corresponding protein entitled steap-1 useful in treatment and detection of cancer |
| 08/14/2003 | WO2003021228A3 Heteroaryl substituted benzothiazole dioxetanes |
| 08/14/2003 | WO2003019145A3 Non-fluorescent quencher compounds and biomolecular assays |
| 08/14/2003 | WO2003018768A3 Transmembrane protein differentially expressed in cancer |
| 08/14/2003 | WO2003014303A3 Molecular interactions in cells |
| 08/14/2003 | WO2003013346A3 Simultaneous imaging of cardiac perfusion and a vitronectin receptor targeted imaging agent |
| 08/14/2003 | WO2003011354A3 Membrane for use with implantable devices |
| 08/14/2003 | WO2002101048A3 NEW POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNα-7 GENE |
| 08/14/2003 | WO2002099108A3 Atp-binding cassette transporter-like molecules and uses thereof |
| 08/14/2003 | WO2002092849A3 Methods |
| 08/14/2003 | WO2002074994A3 Improved orestes sequencing method |
| 08/14/2003 | WO2002074988A3 Arrays and methods of use |